1195 related articles for article (PubMed ID: 27639844)
61. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
62. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy.
Erken R; Zaaijer HL; Willemse SB; Bakker E; Takkenberg BB; Reesink HW; Kootstra NA
Ann Hepatol; 2021 Dec; 26():100540. PubMed ID: 34583061
[TBL] [Abstract][Full Text] [Related]
63. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.
Wong DK; Yuen MF; Yuan H; Sum SS; Hui CK; Hall J; Lai CL
Hepatology; 2004 Sep; 40(3):727-37. PubMed ID: 15349913
[TBL] [Abstract][Full Text] [Related]
64. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
65. Hepatitis B virus: new therapeutic perspectives.
Lin CL; Yang HC; Kao JH
Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
[TBL] [Abstract][Full Text] [Related]
66. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
67. [Quantitative analyses of intrahepatic HBV cccDNA and serum HBsAg in 54 patients with chronic hepatitis B].
Li WJ; Li BA; Zhao JM; Han JQ; Liu Y; Jiang L; Mao YL; Lu FM; Xu DP
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):815-7. PubMed ID: 22433301
[TBL] [Abstract][Full Text] [Related]
68. Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.
Uchida T; Imamura M; Hayes CN; Hiraga N; Kan H; Tsuge M; Abe-Chayama H; Zhang Y; Makokha GN; Aikata H; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696237
[TBL] [Abstract][Full Text] [Related]
69. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Buster EH; Schalm SW; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
[TBL] [Abstract][Full Text] [Related]
70. Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.
Yu S; Zhou Q; Zhao XM; Yuan M; Wang CT; Cheng XG; Zhang ZH; Li X
Saudi J Gastroenterol; 2014; 20(6):350-5. PubMed ID: 25434315
[TBL] [Abstract][Full Text] [Related]
71. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
[TBL] [Abstract][Full Text] [Related]
72. Smaller reduction of hepatitis B virus DNA in liver tissue than in serum in patients losing HBeAg.
Tripodi G; Larsson SB; Norkrans G; Lindh M
J Med Virol; 2017 Nov; 89(11):1937-1943. PubMed ID: 28464339
[TBL] [Abstract][Full Text] [Related]
73. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
[TBL] [Abstract][Full Text] [Related]
74. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.
Jansen L; Kootstra NA; van Dort KA; Takkenberg RB; Reesink HW; Zaaijer HL
J Infect Dis; 2016 Jan; 213(2):224-32. PubMed ID: 26216905
[TBL] [Abstract][Full Text] [Related]
75. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis.
Lenci I; Marcuccilli F; Tisone G; Di Paolo D; Tariciotti L; Ciotti M; Guenci T; Perno CF; Angelico M
Dig Liver Dis; 2010 Aug; 42(8):578-84. PubMed ID: 20097143
[TBL] [Abstract][Full Text] [Related]
76. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH; Keeffe EB
J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
[TBL] [Abstract][Full Text] [Related]
77. Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Menting S; Weegink CJ; Terpstra V; Cornelissen M; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):952-60. PubMed ID: 20150816
[TBL] [Abstract][Full Text] [Related]
78. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
Reijnders JG; Perquin MJ; Zhang N; Hansen BE; Janssen HL
Gastroenterology; 2010 Aug; 139(2):491-8. PubMed ID: 20381492
[TBL] [Abstract][Full Text] [Related]
79. [Intrahepatic hepatitis B virus covalently closed circular DNA correlation with serum HBV DNA, serum HBsAg, alanine aminotransferase and age].
Xie Q; Jiang X; Zhang Y; Hu X; Li X; Li J; Zhu S; Cai W
Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):418-21. PubMed ID: 26236926
[TBL] [Abstract][Full Text] [Related]
80. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B.
Laras A; Papatheodoridi M; Panopoulou E; Papatheodoridis GV; Hadziyannis SJ; Hadziyannis E
Virol J; 2022 Jan; 19(1):22. PubMed ID: 35093105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]